undamentalytics Newsletter
Sign in

Alpha Teknova, Inc. income statement

In fiscal 2025, Alpha Teknova, Inc. reported revenue of $40.5m, up 7.4% on the year before, operating income of −$17.0m (a -41.9% margin) and net income of −$17.3m, or −$0.32 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue31374137384144
Cost of revenue14192426312729
Gross profit1818171071315
Research and development2486322
Selling and marketing2499678
General and administrative8202825232020
Operating income5−12−50−36−26−17−16
Net interest income0−10−1−1−1−1
Income before tax5−13−49−37−27−17−17
Income tax1−3−2−0−000
Net income4−10−47−37−27−17−17
Diluted EPS$0.04−$0.61−$1.69−$1.16−$0.57−$0.32−$0.31
Diluted shares (average)15m16m28m32m47m53m54m
EBITDA7−9−46−30−20−11−10

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: OABI vs TKNORPID vs TKNOCSBR vs TKNO

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Alpha Teknova, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Alpha Teknova, Inc.